Invention Grant
- Patent Title: Platinum compounds for binding guanine quadruplexes
-
Application No.: US16761310Application Date: 2018-11-06
-
Publication No.: US11492366B2Publication Date: 2022-11-08
- Inventor: Caitlin Miron , Anne Petitjean , Jean-Louis Mergny
- Applicant: QUEEN'S UNIVERSITY AT KINGSTON , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Applicant Address: CA Kingston; FR Paris
- Assignee: QUEEN'S UNIVERSITY AT KINGSTON,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee: QUEEN'S UNIVERSITY AT KINGSTON,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee Address: CA Kingston; FR Paris
- Agency: Licata & Tyrrell P.C.
- Agent Angela Lyon
- International Application: PCT/CA2018/051399 WO 20181106
- International Announcement: WO2019/084696 WO 20190509
- Main IPC: C07F15/00
- IPC: C07F15/00 ; A61P35/00 ; A61K31/555 ; A61K31/728 ; A61K38/17 ; A61K38/36 ; A61K38/38 ; A61K39/395 ; G01N33/52 ; C07F13/00 ; C07F11/00
Abstract:
Compounds are described and characterized that bind guanine quadruplexes of DNA or RNA. Binding data and inhibition of growth data of five cancer cell lines are presented.
Public/Granted literature
- US20210188889A1 PLATINUM COMPOUNDS FOR BINDING GUANINE QUADRUPLEXES Public/Granted day:2021-06-24
Information query
